Quinine-induced inhibition of gastrointestinal transit in mice: Possible involvement of endogenous opioids

European Journal of Pharmacology

Volumn 364, Issue 2-3, 1999, Pages 193-197

  Santos, Flávia A ^a   Rao, Vietla S N ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

ATP sensitive K+ channel; Intestinal transit; Morphine; Mouse; Naloxone; Quinine; Yohimbine

Indexed keywords

CINCHONA ALKALOID; GLIBENCLAMIDE; MINOXIDIL; MORPHINE; NALOXONE; OPIATE; OPIATE ANTAGONIST; POTASSIUM CHANNEL; QUININE; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GASTROINTESTINAL TRANSIT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOSINE TRIPHOSPHATE; ADRENERGIC ALPHA-ANTAGONISTS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; GASTROINTESTINAL TRANSIT; GLYBURIDE; MALE; MICE; MINOXIDIL; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; POTASSIUM CHANNELS; QUININE; YOHIMBINE;

EID: 0032926332     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00842-5     Document Type: Article

References (35)

1. Bateman D.N., Dyson E.H. Quinine toxicity. Adverse drug react. Acute Poisoning Rev. 5:1986;215-233.
2. Bolton, T.B., Beech, D.J., 1992. Potassium channel modulators. In: Weston, A.W., Hamilton, D.C. (Eds.), Smooth Muscle Potassium Channels: Their Electrophysiology and Function. Blackwell, Oxford, pp. 144-180.
3. Boyd A.E. III Sulfonylurea receptors, ion channels, and fruit flies. Diabetes. 37:1988;847-850.
4. Burks T.F., Fox D.A., Hirning L.D., Shook J.E., Porreca F. Regulation of gastrointestinal function by multiple opioid receptors. Life. Sci. 43:1988;2177-2181.
5. ATP channel subunits. Neuron. 18:1997;827-838.
6. + channel in rat ileal smooth muscle. Eur. J. Pharmacol. 271:1994;379-386.
7. Gabay T., Krugliak M., Shalmiev G., Ginsberg H. Inhibition by antimalarial drugs of hemoglobin denaturation and iron release in acidified red blood cell lysates - a possible mechanism of their anti-malarial effect? Parasitology. 108:1994;371-378.
8. Gantner F., Uhlig S., Wendel A. Quinine inhibits release of tumour necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure. Eur. J. Pharmacol. 294:1995;353-355.
9. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.a., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-579.
10. + channels. Neuron. 16:1996;1011-1017.
11. Jacaz-Aigrain E., Bennasr S., Desplanques L., Peralama A., Beaufils F. Severe poisoning risk linked to intravenous administration of quinine. Arch. Pediatr. 1:1994;14-19.
12. Janssen P.A., Jageneau A.H. A new series of potent analgesics: dextro 2,2-diphenyl-3-methyl-4-morpholino-butyrylpyrrolidine and related amides: 1. Chemical structure and pharmacological activity. J. Pharm. Pharmacol. 9:1957;381-400.
13. Lee H.K., Bayguinov O., Sanders K.M. Role of nonselective cation current in muscarinic responses of canine colonic muscle. Am. J. Physiol. 265:1993;C1463-1471.
14. + channels reconstituted from skeletal muscle. Eur. J. Pharmacol. 259:1994;219-222.
15. Malchow R.P., Qian H., Ripps H. A novel action of quinine and quinidine on the membrane conductance of neurons from the vertebrate retina. J. Gen. Physiol. 104:1994;1039-1055.
16. McFadzean I. The ionic mechanism underlying opioid action. Neuropeptides. 11:1988;173-180.
17. + permeability. J. Pharmacol. Exp. Ther. 245:1988;751-760.
18. O'Donohue T.L., Dorsa D.M. The opiomelanotropinergic neuronal and endocrine systems. Peptides. 3:1982;353-395.
19. Ohara I., Naruse M.M., Itokawa Y. The effect of palatability and feeding conditions on digestive functions in rats. J. Am. Coll. Nutr. 15:1996;186-191.
20. Patil B.M., Thakker P.R. Glibenclamide antagonizes the inhibitory effect of morphine on gall bladder emptying. J. Pharm. Pharmacol. 48:1996;320-322.
21. + channel openers delay intestinal transit and have antidiarrheal activity. Eur. J. Pharmacol. 287:1995;207-209.
22. Ramabadram K., Bansinath M. The role of endogenous opioid peptides in the regulation of pain. Crit. Rev. Neurobiol. 6:1990;13-32.
23. + channels. Neuroscience. 25:1988;729-749.
24. Santos F.A., Rao V.S.N. A study of the anti-pyretic effect of quinine, an alkaloid effective against cerebral malaria, on fever induced by bacterial endotoxin and yeast in rats. J. Pharm. Pharmacol. 50:1998;225-229.
25. Starke K., Borowski E., Endo T. Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine. Eur. J. Pharmacol. 34:1975;385-388.
26. Stein C.M., Brown N., Carlson M.G., Campbell P., Wood A.J. Coadministration of glyburide and minoxidil, drugs with opposing effects on potassium channels. Clin. Pharmacol. Ther. 61:1997;662-668.
27. Stein C., Millan M.J., Shippenberg T.S., Peter K., Hertz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 248:1989;1269-1275.
28. +/channel openers relax longitudinal muscle of guinea pig ileum. Eur. J. Pharmacol. 271:1994;453-459.
29. Sunita De.Sa., D'Souza R.D., Dhume V.G. Glibenclamide does not antagonize the intestinal actions of morphine. Ind. J. Pharmacol. 26:1994;133-135.
30. Tracy, J.W., Webster, L.T., 1996. Drugs used in the chemotherapy of protozoal infections. In: Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddonand, R.W., Gilman, A.G. (Eds.), The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp. 980-981.
31. White N.J. Antimalarial pharmacokinetics and treatment regimens. Br. J. Clin. Pharmacol. 34:1992;1-10.
32. Wirima J.J., Khormana C.O., Macheso A.F., Heymann D.L., Cambella C.C. In vivo efficacy of quinine treatment for Plasmodium falciparum malaria in Malawian children. Ann. Trop. Med. Parasitol. 84:1990;223-227.
33. Yamamoto T., Kakehata S., Yamada T., Saito T., Saito H., Akaaike N. Effects of potassium channel blockers on the acetylcholine-induced currents in dissociated outer hair cells of guinea pig cochlea. Neurosci. Lett. 236:1997;79-82.
34. Zadina J.E., Hackler L., Ge L., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-501.
35. 2 by chlorquine, quinine, and arteether. J. Parasitol. 79:1993;565-570.